Artificial intelligence (AI) for science has rapidly gained momentum at an extreme pace. Models trained on the scientific record are generating hypotheses and even running experiments in automated ...

In today’s ACT Brief, we look at how artificial intelligence is reshaping drug development decisions across pharma, discuss ...

An MIT team used artificial intelligence to design novel antibiotics, two of which showed promise against MRSA and gonorrhea. With help from artificial intelligence, MIT researchers have designed ...

ChatGPT maker OpenAI on Thursday said it will invest in a startup focused on blocking bad actors from creating biological ...

In this webinar, Jae Chang Lim and Hyun Joon Chang will discuss how a cutting-edge artificial intelligence platform is transforming early-stage drug discovery.

OpenAI is expanding its efforts to contain emerging risks posed by artificial intelligence, backing a new biotech spinoff aimed at stopping malicious actors from using advanced models to create ...

Existing frameworks for explainable artificial intelligence (XAI) and AI governance, such as the EU AI Act and the NIST AI ...

Its mind-boggling complexity is probably a factor in why quantum has ended up with a lower profile than tech's current ...

Harvard and Northwestern researchers combine AI and physics to design unstable proteins that comprise the dark proteome.

Emerging data suggests yes. Recent reviews reveal that AI-generated drugs achieve Phase I success rates of 80-90% , compared ...